Shanghai, China, and Chicago, USA, December 23, 2021 - Reistone Biopharma (“Reistone”), a global biotechnology company focused on development of treatments for immune and inflammation related diseases
Reistone announces presentation at the 40th Annual J.P. Morgan Healthcare conference in January 2022